Foghorn Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!